VINC
Vincerx Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.02
+0.00%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$8.00
- Revenue estimate
- —
Latest reported
- Last report date
- May 15, 2025
- EPS actual
- -$0.91
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +15.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 15, 2025 | — | -$0.91 | — | — |
| Mar 27, 2025 | -$3.40 | -$4.20 | Miss -23.53% | — |
| Aug 8, 2024 | -$3.40 | -$1.00 | Beat 70.59% | — |
| May 14, 2024 | -$5.20 | -$6.80 | Miss -30.77% | — |
| Mar 29, 2024 | -$8.40 | -$4.60 | Beat 45.24% | $1.3M |
| Nov 14, 2023 | -$9.80 | -$9.20 | Beat 6.12% | — |
| May 11, 2023 | -$14 | -$14 | Beat 1.45% | — |
| Nov 10, 2022 | -$16 | -$16 | In line | — |
| Aug 11, 2022 | -$18 | -$18 | Beat 4.35% | — |
| May 12, 2022 | -$0.76 | -$0.79 | Miss -3.95% | — |
| Nov 12, 2021 | -$0.85 | -$1.39 | Miss -63.53% | — |
| Aug 12, 2021 | -$0.37 | -$0.12 | Beat 67.57% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026